Logo

Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline

Share this

Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline

Shots:

  • Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
  • The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
  • The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment- an early indicator of certain forms of dementia such as AD

 ­ Ref: Biogen | Image: Biogen

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions